About us.
Find out how we’re transforming ideas into impact at scale through the businesses we identify, back and grow.
Our portfolio.
Investors.
We have a proven track-record in backing and nurturing science and technology-based businesses to deliver a better future for people and planet.
Our impact.
Find out how we’re living our purpose and identifying, backing and growing businesses that contribute to a healthier, tech-enriched, sustainable future.
News & Events.
Open and close mobile menu
IP Group news
17 Nov 2025
Portfolio company Artios completes oversubscribed $115m Series D financing round
IP Group plc
13 Oct 2025
Update on potential future royalty income from Metsera obesity drug candidates
08 Oct 2025
Portfolio company Monolith to be acquired by CoreWeave
Portfolio news
26 Nov 2025
Istesso provides updates on leramistat and next-generation programs
Istesso Ltd
Artios announces oversubscribed $115m Series D financing to accelerate clinical programs in indications of high unmet need
Artios Pharma Ltd
13 Nov 2025
RAGE Biotech secures $A29 million in Series A funding. Appoints Siro Perez as Chief Executive Officer & Edwin Tucker as Chief Medical and Development Officer
RAGE Biotech
07 Nov 2025
08 Aug 2025
17
Virtual
Event has passed
26
45 Gresham Street, London
12
Hybrid
